TEMPO 451506H0Recalls & reported problems
Cordis Corporation · CATH TEMP0 5 MPA1 (1) 100CM · Class 2
Data updated Oct 13, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 2
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 10705032008334), received between Mar 25, 2020 and May 24, 2024 — classified as 1 injury, 1 malfunction.
The most frequently reported specific device problem is “Detachment of Device or Device Component” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.
Reports received per month
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem1
- Detachment of Device or Device Component1
Patient problems
- No Consequences Or Impact To Patient1
- Pericardial Effusion1
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
InjuryMay 24, 2024Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
AS REPORTED, WHILE ESTABLISHING A TRACK FOR THE DELIVERY OF AN UNKNOWN PATENT DUCTUS ARTERIOSUS (PDA) OCCLUDER WITH A 5F 100CM MULTIPURPOSE (MPA) TEMPO DIAGNOSTIC CATHETER, THE PATIENT¿S HEART RATE DROPPED TO 30 BEATS PER MINUTE, AND OXYGENATION DROPPED TO UNMEASURABLE LEVELS. A BEDSIDE CARDIAC ULTRASOUND WAS PERFORMED AND REVEALED A PERICARDIAL EFFUSION. THE DEVICE WAS REMOVED AND A PERICARDIOCENTESIS WAS PERFORMED. BLOODY FLUID WAS EXTRACTED, AND THE PATIENT WAS OBSERVED; HOWEVER, THE EFFUSION CONTINUED TO GRADUALLY INCREASE AFTER THE EXTRACTION OF FLUID. THE PATIENT¿S HEART RATE AND OXYGEN LEVELS RETURNED TO NORMAL, BUT DUE TO THE PERICARDIAL EFFUSION CONTINUING TO INCREASE, EMERGENCY CARDIAC SURGERY WAS PERFORMED. THE SURGICAL PROCEDURE WAS SUCCESSFUL, AND THE PATIENT WAS DISCHARGED AFTER THE SURGERY. THE TEMPO CATHETER WAS USED TO DELIVER THE UNKNOWN PDA OCCLUDER. THERE WAS NO DIFFICULTY PLACING THE UNKNOWN PDA OCCLUDER THROUGH THE 5F TEMPO CATHETER. THE DEVICE WAS DISCARDED AND WILL NOT BE RETURNED. THE HOSPITAL REPORTED IT AS AN ADVERSE EVENT TO THE CHINA NMPA DIRECTLY.
Patient problems: Pericardial Effusion
MAUDE report 19392472 ↗MalfunctionMar 25, 2020Detachment of Device or Device Component; Detachment of Device or Device Component
DURING PHLEBOGRAPHY PROCEDURE, THE 5F 100CM TEMPO CATHETER HAD DIFFICULTY PASSING THROUGH THE ANATOMY AND FRACTURED WHEN ROTATED WHICH BEING LEFT IN TWO. THE FRACTURED PART WAS RECOVERED BY THE DOCTOR BY PULLING EVERYTHING AS SEPARATION STARTED NEAR THE INTRODUCER AND THE GUIDEWIRE WAS INSIDE THE CATHETER. IT DID NOT REQUIRE SECONDARY INTERVENTION. ANOTHER CATHETER WAS PASSED AND THE CASE COULD BE COMPLETED. THERE WAS NO VESSEL INJURY. THE PATIENT¿S CURRENT CONDITION IS NORMAL. THERE WERE NO ABNORMALITIES WHEN THE DEVICE WAS REMOVED FROM THE PACKAGE NOR OBSERVED DURING PREPARATION. THE DEVICE WAS NOT RESTERILIZED. THE DEVICE WAS INSERTED DIRECTLY INTO THE SHEATH INTRODUCER. THE LESION WAS NOT CALCIFIED. THERE WAS NO PRESENCE OF TORTUOSITY NOR ANGULATION. THERE WAS NO STENOSIS. THE DEVICE WAS NOT USED FOR CHRONIC TOTAL OCCLUSION (TOTAL OCCLUSION> 3 MONTHS) AS THE VESSEL IS HEALTHY WITHOUT ANY INJURY OR OCCLUSION. THERE WAS NO RESISTANCE ENCOUNTERED WHEN REMOVING THE DEVICE. THE DEVICE DETACHED FROM THE MANIPULATION AREA CLOSE TO THE INTRODUCER. THE DOCTOR DID NOT SLAP THE BROKEN END. THE GUIDEWIRE USED IN THE PROCEDURE WAS NON-CORDIS. THE DEVICE WILL NOT BE RETURNED FOR EVALUATION.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 9880245 ↗
Other CATHETER, INTRAVASCULAR, DIAGNOSTIC devices
- TrapEase Permanent Vena Cava Filter with the VisEase Angiographic Vessel Dilator 466P306AUCordis Corporation · CATHETER, INTRAVASCULAR, DIAGNOSTIC6 deaths186 reports
- Dragonfly™ OPTIS™ C408646Lightlab Imaging, Inc. · CATHETER, INTRAVASCULAR, DIAGNOSTIC4 deaths150 reports
- Dragonfly OpStar™ 1014651Lightlab Imaging, Inc. · CATHETER, INTRAVASCULAR, DIAGNOSTIC1 recall87 reports
- LANGSTON IPN913559Teleflex Incorporated · CATHETER, INTRAVASCULAR, DIAGNOSTIC2 recalls14 reports
- Trevo 90238Stryker Corporation · CATHETER, INTRAVASCULAR, DIAGNOSTIC2 recalls5 reports
- Expo™ H749085263011Boston Scientific Corporation · CATHETER, INTRAVASCULAR, DIAGNOSTIC2 recalls3 reports
- Expo™ H74908526501Boston Scientific Corporation · CATHETER, INTRAVASCULAR, DIAGNOSTIC2 recalls1 report
- Expo™ H74908526031Boston Scientific Corporation · CATHETER, INTRAVASCULAR, DIAGNOSTIC2 recalls0 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 13, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 13, 2026
- Page last rebuilt: Oct 13, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page